Last reviewed · How we verify
NaCl 0.9% in Glucose 5% with 40mEq Potassium
NaCl 0.9% in Glucose 5% with 40mEq Potassium is a Small molecule drug developed by University Hospital, Antwerp. It is currently FDA-approved.
At a glance
| Generic name | NaCl 0.9% in Glucose 5% with 40mEq Potassium |
|---|---|
| Sponsor | University Hospital, Antwerp |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- NaCl 0.9% in Glucose 5% with 40mEq Potassium CI brief — competitive landscape report
- NaCl 0.9% in Glucose 5% with 40mEq Potassium updates RSS · CI watch RSS
- University Hospital, Antwerp portfolio CI
Frequently asked questions about NaCl 0.9% in Glucose 5% with 40mEq Potassium
What is NaCl 0.9% in Glucose 5% with 40mEq Potassium?
NaCl 0.9% in Glucose 5% with 40mEq Potassium is a Small molecule drug developed by University Hospital, Antwerp.
Who makes NaCl 0.9% in Glucose 5% with 40mEq Potassium?
NaCl 0.9% in Glucose 5% with 40mEq Potassium is developed and marketed by University Hospital, Antwerp (see full University Hospital, Antwerp pipeline at /company/university-hospital-antwerp).
What development phase is NaCl 0.9% in Glucose 5% with 40mEq Potassium in?
NaCl 0.9% in Glucose 5% with 40mEq Potassium is FDA-approved (marketed).